cGxP.wire https://validator.w3.org/feed/docs/rss2.html Gilead Sciences and Merck & Co. Deliver Positive ISLEND Phase 3 Results AstraZeneca’s Etcamah Approved for First-Line Breast Cancer Gilead Sciences Secures CHMP Support for Trodelvy Plus KEYTRUDA Repligen’s $1.5B BioLife Deal Expands CGT Portfolio Atsena Therapeutics Secures EMA Orphan Status for Two Gene Therapies HCW Biologics Reaches FDA Pre-IND Milestone for HCW11-018b Inhibikase Gains FDA Orphan Drug Status for IKT-001 in PAH Genmab and AbbVie Clarify EPCORE DLBCL-1 Phase 3 Results MacroGenics Reports Positive Phase 1 MGC026 Cancer Study Update Ipsen Announces Phase III BOLD Results for Bylvay in Biliary Atresia Sanofi Ends Amlitelimab Development for Atopic Dermatitis Roche’s Susvimo Receives Positive CHMP Opinion for EU Approval Cosmetic Physician Partners Returns $35 Million to Employee Owners Nona Biosciences and MedUni Vienna Collaborate on Infectious Diseases Nuvectis Pharma Announces China Approval of Ciprocopan for PNH Autonomix Medical Secures New U.S. Patent for Precision Neuromodulation Platform GHIT Fund Accelerates Portable Ebola Diagnostic Innovation Verastem Oncology Doses First Patient in Phase 2 VS-7375 NSCLC Trial Penumbra THUNDERBOLT Shows Strong Stroke Trial Results Pfizer Inc. Wins FDA Priority Review for Prostate Cancer Therapy Xodus Medical Study Validates Hot Pink Pad Performance Dexcom Selected as First Participant in FDA TEMPO Pilot Program GSK Wins FDA Approval for Jideytro in ROS1+ Lung Cancer Ibex Medical Analytics Strengthens Breast Cancer AI with CE-IVDR Approval Ribo Unveils Positive Phase 2a Data for Vortosiran in CAD Ascletis Reports Superior ASC36_35 Weight Loss Data at EASD 2026 BeOne Medicines Scales Cancer Drug Production in the U.S. Lakewood-Amedex Highlights Nu-3 Against Antibiotic Resistance Azafaros Finishes Patient Enrollment in NAVIGATE Phase 3 Trial LB Pharmaceuticals Accelerates Phase 3 LB-102 Schizophrenia Timeline Artelo Biosciences Advances ART12.11 Following CBD Research Review Co-Diagnostics Targets India TB Diagnostics with PCR Pro Studies BridgeBio Announces FDA Acceptance of Encaleret NDA for ADH1 Oncotelic Publishes Deciparticle Data Supporting Sapu003 Clinical Trial Serenity Medical Reports Long-Term River Stent Success in IIH Revolution Medicines FDA Accepts Daraxonrasib NDA for Pancreatic Cancer NMD Pharma Identifies New Cause of Age-Related Muscle Weakness IMNN-001 Demonstrates Clinical Promise in Advanced Ovarian Cancer Myriad Launches FirstGene for Earlier Prenatal Genetic Screening Serina Therapeutics Completes First Cohort in SER-252 Phase 1 Trial Junshi Expands Toripalimab to Stage II-III NSCLC Merakris Therapeutics Wins NIH Funding for MTX-001 Alpha Tau Medical Ltd. Reports Positive Head and Neck Cancer Results Intelligent Bio Solutions Completes FDA 510(k) Precision Testing Milestone Natera Reports Signatera Superior to AMERK in MCC Monitoring Arrowhead Pharmaceuticals Reports Positive Phase 3 Plozasiran Results Johnson & Johnson FDA Clears OTTAVA Robotic Surgical System Envoy Medical Advances Acclaim Cochlear Implant Trial Seek Labs Validates ANINA Molecular Diagnostic Platform Healx Doses First Patient in HLX-4310 Phase 1/2 Trial